- ►prsjournal.com PJ Rosenfeld - British Journal of Ophthalmology, 2007 - bjo.bmj.com The same progression of events is now taking place in the use of Avastin for CNV
secondary to pathological myopia. Last year, Nguyen et al 27 reported on the use
of systemic Avastin for the treatment of subfoveal CNV secondary to ... Cited by 10 - Related articles - BL Direct - All 7 versions
JM Ruiz-Moreno, F Gomez-Ulla, JA Montero, S … - Eye, 2009 - phx1.medscape.com New antiangiogenic drugs have been made available to treat subfoveal CNV
secondary to high myopia, although there have not been too many reports yet.
[11-20] The purpose of this pilot study is to evaluate the outcome of ... Cited by 16 - Related articles - All 8 versions
- ►prsjournal.com D Wong, KKW Li - British Journal of Ophthalmology, 2008 - bjo.bmj.com There are a growing number of publications supporting the use of Avastin
(bevacizumab) for choroidal neovascularisation (CNV) secondary to pathological
myopia (table 1).1 – 8 In this issue, Arias et al (see page 1035) ... Cited by 1 - Related articles - All 4 versions
JM Ruiz-Moreno, A Artola, MJ Ayala, P … - Journal of Cataract & Refractive Surgery, 2000 - Elsevier To evaluate the incidence, characteristics, and results of treatment of
choroidal neovascularization (CNV) in myopic eyes corrected by photorefractive
keratectomy (PRK). ... University Miguel Hernández, Instituto ... Cited by 7 - Related articles - BL Direct - All 7 versions
K Sayanagi, Y Ikuno, K Soga, T Wakabayashi … - Acta Ophthalmol (Copenh), 2008 - interscience.wiley.com Cases report: Three eyes of three patients with mCNV were examined with
fluorescein angiography (FA) and ICGA using Heidelberg Retinal Angiograph 2 and
the conventional fundus camera before and after IVB. The cessation of ... Cited by 3 - Related articles - All 3 versions
S Mandal, P Venkatesh, R Sampangi, S Garg - European journal of ophthalmology - ncbi.nlm.nih.gov PURPOSE: To evaluate the short-term efficacy and safety of intravitreal
bevacizumab in myopic choroidal neovascularization (mCNV). METHODS: In this
noncomparative, consecutive, interventional case series, 12 eyes of 11 ... Cited by 19 - Related articles - BL Direct - All 3 versions
- ►prsjournal.com ML HERNÁNDEZ-ROJAS, H Quiroz-Mercado, … - Retina, 2007 - journals.lww.com Methods: In this prospective interventional case series, patients were treated
with 2.5 mg of intravitreal bevacizumab and followed for 3 months.
Best-corrected visual acuity (BCVA), optical coherence tomography (OCT), ... Cited by 35 - Related articles - BL Direct - All 3 versions
WM Chan, TYY Lai, AL Wong, DTL Liu, DSC … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: At 1 year, the logMAR best-corrected visual acuity (BCVA) for the
combined PDT with IVTA group changed from 0.62 to 0.61 (p = 0.74), whereas that
for the monotherapy group changed from 0.61 to 0.67 (p = 0.33). The mean ... Cited by 22 - Related articles - BL Direct - All 5 versions
JM Ruiz-Moreno, C de la Vega, O Ruiz-Moreno, … - Journal of Cataract & Refractive Surgery, 2003 - Elsevier Choroidal neovascularization occurred in 5 eyes (1.70%); 3 eyes were in women,
and 2 were in men. The interval between PACL implantation and CNV was 63.2 ±
27.3 months (range 18 to 87 months). The CNV was subfoveal in 4 eyes and ... Cited by 14 - Related articles - All 9 versions
